Point72 Hong Kong’s InflaRx IFRX Stock Holding History

Point72 Hong Kong’s Portfolio IFRX Stock Details IFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-24	Closed	–	–	1267
2020 Q1	$0	Buy	+24	New	+$89	﹤0.01%	1131
2019 Q2	–	Sell	-24	Closed	-$1K	–	1248
2019 Q1	$1K	Hold	24	–	–	﹤0.01%	944
2018 Q4	$1K	Buy	+24	New	+$739	﹤0.01%	794

Other funds holding IFRX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Point72 Hong Kong's IFRX Position: Q2 2020 in Review

Point72 Hong Kong sold out of InflaRx (IFRX) in Q2 2020, closing a stake of 24 shares.

Point72 Hong Kong first reported a position in IFRX in Q4 2018 and held it in 3 quarters. The position peaked at $1K in Q1 2019. 35 funds tracked by Wall St. Rank hold IFRX as of Q2 2020.

Point72 Hong Kong reported no remaining InflaRx position as of Q2 2020 after selling out during the quarter.
Point72 Hong Kong sold 24 InflaRx shares in Q2 2020.
Point72 Hong Kong first reported a position in InflaRx in Q4 2018 and held it in 3 quarters.
Point72 Hong Kong's InflaRx position peaked at $1K in Q1 2019.
35 funds tracked by Wall St. Rank held InflaRx as of Q2 2020.

Based on Point72 Hong Kong's 13F filing for Q2 2020, filed 14 Aug 2020.